HSA — authorised 6 June 2014
- Marketing authorisation holder: DOW PHARM
- Status: likely_approved
HSA authorised Jublia on 6 June 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 6 June 2014.
DOW PHARM holds the Singaporean marketing authorisation.